egfr non–small cell lung cancer: frontline options
Published 6 years ago • 302 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
5:55
a case of egfr-mutant non–small cell lung cancer
-
20:24
targeted treatment with egfr tkis: front line options
-
0:58
first line treatment options for activating egfr non-small cell lung cancer | dr. alexander spira
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
5:54
frontline alk, egfr inhibition in non-small cell lung cancer
-
5:53
targeted therapy in non-small cell lung cancer
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
5:13
case 2: frontline therapy in egfr-mutated lung cancer
-
5:50
targeted therapy in egfr exon 20-mutant non–small cell lung cancer
-
4:03
approaching a case of egfr non–small cell lung cancer
-
3:22
treatment options: newly diagnosed egfr nsclc
-
4:47
treating non–small cell lung cancer with an egfr exon 20 insertion
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
2:26
egfr mutations in nsclc
-
3:24
treatment options at relapse for egfr-mutated nsclc
-
6:50
treatment options for egfr nsclc
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
3:55
egfr-mutant nsclc: optimizing therapy selection
-
0:48
current role of immunotherapy in egfr-mutant lung cancer